at www.tipranks.com (Wed, 18-Nov 5:01 AM)
Lexeo Therapeutics, Inc. (LXEO) Receives a Buy from Leerink Partners
at www.tipranks.com (Tue, 17-Nov 8:25 AM)
Lexeo’s Promising LX2020 Results and FDA Pathway Support a Positive Outlook
at www.tipranks.com (Tue, 17-Nov 7:26 AM)
at www.tipranks.com (Tue, 17-Nov 1:01 AM)
Lexeo cardiomyopathy asset data prompts Street price target increases
at seekingalpha.com (Mon, 16-Nov 2:06 PM)
Lexeo’s LX2020 Results Strengthen Therapeutic Outlook; Buy Reiterated
at www.tipranks.com (Mon, 16-Nov 10:55 AM)
Lexeo Reports Interim LX2020 Data in Cardiomyopathy Trial
at www.tipranks.com (Mon, 16-Nov 8:27 AM)
Lexeo Therapeutics GAAP EPS of -$0.43 misses by $0.10
at seekingalpha.com (Mon, 16-Nov 8:19 AM)